HELX vs. THNR ETF Comparison
Comparison of Franklin Genomic Advancements ETF (HELX) to Amplify Weight Loss Drug & Treatment ETF (THNR)
HELX
Franklin Genomic Advancements ETF
HELX Description
Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovation
Grade (RS Rating)
Last Trade
$32.02
Average Daily Volume
2,284
49
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.Grade (RS Rating)
Last Trade
$26.56
Average Daily Volume
3,097
6
Performance
| Period | HELX | THNR |
|---|---|---|
| 30 Days | -3.78% | -5.78% |
| 60 Days | -2.32% | 2.38% |
| 90 Days | 2.25% | 2.59% |
| 12 Months | 15.70% |
HELX Overweight 46 Positions Relative to THNR
| Symbol | Grade | Weight | |
|---|---|---|---|
| MEDP | F | 5.6% | |
| VRTX | D | 5.35% | |
| DHR | C | 5.34% | |
| REGN | D | 5.19% | |
| KRYS | D | 4.27% | |
| NTRA | A | 3.82% | |
| BRKR | D | 2.32% | |
| CTVA | A | 2.22% | |
| A | B | 2.21% | |
| IONS | F | 2.18% | |
| INSM | D | 2.06% | |
| CDNS | D | 2.05% | |
| CRL | F | 1.95% | |
| QGEN | D | 1.94% | |
| BNTX | B | 1.89% | |
| ALNY | C | 1.83% | |
| UTHR | C | 1.77% | |
| EXAS | C | 1.68% | |
| ICLR | F | 1.6% | |
| SRPT | F | 1.56% | |
| RCKT | F | 1.49% | |
| RARE | C | 1.41% | |
| TWST | D | 1.26% | |
| IQV | F | 1.13% | |
| TECH | C | 1.01% | |
| AZTA | F | 0.96% | |
| MRNA | F | 0.92% | |
| CDMO | C | 0.88% | |
| BEAM | F | 0.88% | |
| BBIO | F | 0.86% | |
| NBIX | F | 0.82% | |
| LGND | D | 0.82% | |
| NTLA | F | 0.81% | |
| VYGR | F | 0.81% | |
| CRSP | F | 0.63% | |
| RXRX | F | 0.62% | |
| FDMT | F | 0.57% | |
| RGEN | F | 0.56% | |
| AVTR | D | 0.52% | |
| BIO | B | 0.51% | |
| BMY | B | 0.29% | |
| SLP | F | 0.28% | |
| VCYT | C | 0.24% | |
| BMRN | F | 0.21% | |
| DVAX | D | 0.19% | |
| ARE | D | 0.16% |
HELX: Top Represented Industries & Keywords
THNR: Top Represented Industries & Keywords
Compare ETFs
